Rocket Lab's Iridium Takeover Is Fully Funded — Now the Regulators Get Their Turn
Published on 09/18/2026 at 09:20 | Editorial boerse-global.de
Rocket Lab has removed the last financial obstacle from its multibillion-dollar purchase of satellite operator Iridium Communications. A stock offering worth $1.944 billion closed successfully, and Iridium simultaneously reworked its existing credit facility, a $1.775 billion arrangement. With that, the acquisition is fully financed — a milestone that gives investors a clear picture of the capital structure, though it does not yet mean the deal has closed.
What stands between the company and completion is now purely a matter of approvals. The FCC has accepted the license-transfer applications tied to the takeover and opened a public comment period — an initial formal step, not a green light. Shareholder and regulatory sign-offs remain outstanding, and that sequence, money secured but consents pending, is what is currently driving how the market prices the stock.
The shares reflected that mix of progress and uncertainty in recent sessions. Rocket Lab climbed 6.7% on Thursday and finished the week up roughly 9%, with pre-market indications later putting the stock at EUR 60.10, about 1.7% above the prior day's close.
A sector running short on rockets
The backdrop explains part of the enthusiasm. At the Glenn Space Technology Symposium in Ohio on Wednesday, industry figures warned of a structural bottleneck in launch capacity. SpaceX is shifting resources away from Falcon 9 toward Starship. Blue Origin's New Glenn has been idle since an explosion on the pad in May. United Launch Alliance's Vulcan Centaur has been grounded since February following a booster anomaly. Meanwhile NASA is projecting more than a thousand launches and re-entries per year through 2030. The obvious question: who flies all of it?
Rocket Lab is positioning itself squarely in that gap. Its Electron program has already completed its 16th mission this year, and the company is pushing ahead on the product side as well. With IMM Apex, it has brought a germanium-free solar cell for satellite applications to market readiness, strengthening its higher-margin components business.
Should investors sell immediately? Or is it worth buying Rocket Lab?
What Iridium actually brings
The strategic case rests less on the roughly $8 billion price tag than on what comes with it. Iridium contributes recurring revenue from satellite communications: more than $870 million in annual sales, 66 satellites and 2.5 million subscribers. Bolting that onto Rocket Lab's launch and space-systems operations would turn a cyclical rocket builder into a company with a stable subscription foundation.
The standalone numbers are compelling even without Iridium. Second-quarter revenue reached $234 million, up 62% year over year, with Space Systems alone growing 94%. The order backlog climbed to $2.36 billion, a gain of 137%, nearly half of it due within twelve months. Observers expect more than $1.5 billion in revenue for 2027 — a figure that already excludes Iridium.
Raymond James Financial upgraded the stock to "Moderate Buy" on September 12, a sign that at least one analyst house views the strategic logic of the combination favorably. Closing is targeted for mid-2027. SpaceX, for its part, has asked the FCC to examine Iridium's conduct toward competitors — without challenging the deal itself.
Neutron is the real long-term test
While the Iridium story grabs headlines, the stock's fate over the longer horizon hinges on a different project: the new Neutron rocket. Pre-flight tests on the "Hungry Hippo" fairing system wrapped up this week, a ten-meter test stand in Virginia is in place, and a test of the thrust modules at the launch mount comes next, followed by a wet dress rehearsal and a static fire.
Neutron is designed to carry 13 tonnes to low Earth orbit at a target price of $50 million to $55 million, with 10 to 20 flights per booster. The first launch from the pad is targeted for the fourth quarter of 2026 — a date that is not yet locked in.
Not everything is going smoothly. Rocket Lab has filed a formal protest with the U.S. Government Accountability Office over NASA's decision to award a roughly $700 million contract for a Mars telecommunications satellite to Blue Origin, arguing the selection violated criteria set by Congress. Disputes of this kind can drag on and absorb attention while the Iridium integration and the Neutron schedule are already tying up capital and management.
Rocket Lab at a turning point? This analysis reveals what investors need to know now.
Dilution, debt and the chart
The equity raise that closed the Iridium financing carries a cost: roughly 29.3 million new shares enter the market. A previously arranged $3.6 billion bridge loan was cancelled in its place, a move that saves interest expense but dilutes existing holders.
The technical picture remains cautious. The stock trades 15% below its 200-day moving average and 55% below its May 52-week high of EUR 133.80, though it has recovered substantially from its yearly low of EUR 32.60 and sits just under its 50-day average of EUR 60.66. Thirty-day volatility of 42% underscores that the market still expects pronounced swings. With an RSI of 54.2, the shares are neither overbought nor oversold, offering no clear directional signal.
For investors, the situation boils down to a single question: does the Iridium deal close without further delays or conditions? Financing is no longer the risk — the regulatory and corporate-governance calendar is. For a company simultaneously advancing its core Electron business, every delay on Iridium weighs double, tying up management capacity and capital-market confidence. Should the approval process stall, or the NASA dispute turn against Rocket Lab, skepticism is likely to take over. The next concrete tests are the progress of the regulatory reviews around the Iridium transaction and the outcome of the NASA protest — both of which should show in the coming weeks whether Rocket Lab can actually execute its strategic expansion, or whether the process drags on further.
Ad
Rocket Lab Stock: New Analysis - 18 September
Fresh Rocket Lab information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
